期刊文献+

福建海绵放线菌多样性及其次级代谢产物合成能力 被引量:1

Diversity and secondary metabolite biosynthetic potential of actinomycetes associated with a marine sponge in Fujian
下载PDF
导出
摘要 目的分离海洋稀有放线菌并对其进行多样性分析及活性测试。方法采用3种选择性分离培养基从福建海绵中分离放线菌,根据培养特征将分离到的放线菌进行分组,选取各组部分菌种进行16S rRNA基因序列测定并进行系统进化分析,通过BOXPCR指纹进一步分析这些放线菌的多样性。用基于PCR的方法对部分菌株的抗生素生物合成基因进行筛选并对这些菌株的发酵提取液进行抗菌活性测试。结果和结论分离到47株放线菌,根据培养特征将它们分为4组,选取各组部分菌种共23株进行16S rRNA基因序列测定并进行系统进化分析,结果这23株菌在系统进化树上形成6个独立分支(群1~6),分别对应于按培养特征分组的3、2、2、2、1和4组。群1、2、3、4和5属于疣孢菌属(Verrucosispora),群6属于继生菌属(Jishengellal。BOX PCR指纹分析进一步揭示了这些疣孢菌的多样性。基于PCR的基因筛选结果显示97%的菌株具有I型PKS、烯二炔或NRPS生物合成基因片段,抗菌活性测试发现70%的菌株发酵提取液具有抗细菌或真菌活性。 Objective To isolate actinomycetes associated with marine sponge and investigate their diversity and secondary metabolite biosynthetic potentials. Methods A cultivation-based approach was employed to isolate the actinomycetes associated with a marine sponge from East China Sea in Fujian Province. Phylogenetic analysis based on 16S rRNA gene sequences and BOX PCR fingerprint analysis were used to show the diversity of these strains. PCR based gene screening method and antimicrobial assays were used to detect their secondary metabolite biosynthetic potentials. Results and Conclusion A total of 47 strains of actinomycete were isolated by using three different culture media, these strains were assigned to 4 groups by colour grouping. Phylogenetic analysis based on 16S rRNA gene sequences showed that these strains can be classified into 6 distinct clades. Five of the clades belonged to the genus Verrucosispora and one to the genus Jishengella. BOX PCR fingerprint analysis further showed the diversity of these strains. Of the 30 isolates, 97% contained type I PKS, Enediyne PKS or NRPS genes, 70% displayed antimicrobial activity, indicating that these isolates had a high potential to produce active compounds.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2015年第6期407-413,共7页 Chinese Journal of Antibiotics
基金 国家科技重大专项(No.2012ZX09301002-003) 973项目(No.2012CBA01303) 福建省科技平台项目(No.2013Y2003 No.2014Y2001)
关键词 海绵 放线菌 多样性 Sponge Actinomycetes Diversity
  • 相关文献

参考文献25

  • 1BluntJ W, Copp B R, Keyzers R A, et al. Marine natural products[J]. Nat Prod Rep 2014,31: 160-258.
  • 2Thomas T R A, Kavlekar D P, LokaBharathi P A. Marine drugs from sponge-microbe association-a review[J]. Mar Drugs, 2010, 8 (4): 1417-1468.
  • 3Taylor M W, Radax R, Steger D, et al. Sponge-associated microorganisms: Evolution, ecology, and biotechnological potential[J]. Microbial Mol BioI Rev, 2007, 71(2): 295-347.
  • 4Hentschel V, Usher K M, Taylor M W. Marine sponges as microbial fermenters[J]. FEMS Microb Ecol, 2006, 55(2): 167-177.
  • 5KennedyJ, Baker P, Piper C, et al. Isolation and analysis of bacteria with antimicrobial activities from the marine sponge Haliclona simulans collected from irish waters[J]. Mar Biotechnol, 2009, 11: 384-396.
  • 6Khan S, Tamura T, Takagi M, et al. Streptomyces tateyamensis sp. nov., Streptomyces marinus sp. nov. and Streptomyces haliclonae sp. nov., isolated from the marine sponge Haliclona sp.[J] IntJ Syst Evol Microbiol, 2010, 60: 2775-2779.
  • 7Khan S, Komaki H, Motohashi K, et al. Streptomyces associated with a marine sponge Haliclona sp.; biosynthetic genes for secondary metabolites and products[J]. Environ Microbiol, 2011, 13: 391-403.
  • 8iang S, Sun W, Chen M, et al. Diversity of culturable actinobacteria isolated from marine sponge Haliclona sp.[J]. Antonie Van Leeuwenhoek, 2007, 92: 405-416.
  • 9ChunJ, Goodfellow M. A phylogenetic analysis of the genus Nocardia with 16S rRNA gene sequence[J]. IntJ Syst Bacteriol, 1995,45: 240-245.
  • 10ThompsonJ D, Gibson TJ, Plewniak F, et al. The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools[J]. Nucleic Acids Res, 1997,25(24): 4876-4876.

二级参考文献24

  • 1ZangX(臧旭) HuangM(黄敏).Advances in studies of antitumor metabolites from marine microorganisms[J].中国微生态学杂志,22:949-953.
  • 2LiuYL(刘燕兰) XiaoLH(肖丽华) WuM(吴敏) etal.Advances in studies of antitumor metabolites from marine microorganisms[J].中医药导报,13:114-116.
  • 3FuJZ(傅俊曾) JiLX(冀兰鑫) XieCF(谢春锋).Biologically active natural products from Streptomyces microorganisms[J].药物评价研究,33:153-158.
  • 4LiuL(刘丽) HuJC(胡江春) WangSJ(王书锦).Progress in studies on bioactive metabolites of sponge associated microbes[J].天然产物研究与开发,16:477-481.
  • 5Prudhomme J,McDaniel E,Ponts N,et al.Marine actinomycetes:a new surce of compounds against the human malaria parasite.PLoS ONE,2008,3:2335-2338.
  • 6Fiedler HP,Bruntner C,Riedlinger J,et al.Proximicin A,B and C,novel aminofuran antibiotic and anticancer compounds isolated from marine strains of the actinomycete Verrucosispora.J Antibiot (Tokyo),2008,61:158-163.
  • 7Riedlinger J,Reicke A,Zahner H,et al.Abyssomicins,inhibitors of the para-aminobenzoic acid pathway producedby the marine Verrucosispora strain AB-18-032.J Antibiot (Tokyo),2004,57:271-279.
  • 8Shirai M,Okuda M,Motohashi K,et al.Terpenoids produced by actinomycetes:isolation,structural elucidation and biosynthesis of new diterpenes,gifhornenolones A and B from Verrucosispora gifhornensis YM28-088.J Antibiot (Tokyo),2010,63:245-250.
  • 9Furukawa S.In vitro chemosensitivity of hepatocellular carcinoma for hepatic arterial infusion chemotherapy using the MTT assay with the combinations of antitumor drugs.Kurume Med J,2004,51:25-33.
  • 10Xu FM,Morikawa T,Matsuda H,et al.Structures of new sesquiterpenes and hepatoprotective constituents from the egyptian herbal medicine cyperus longus.J Nat prod,2004,67:569-576.

共引文献7

同被引文献14

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部